A carregar...
Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
In recent years, newer drug classes for the treatment of type 2 diabetes mellitus have been released with significant effects on glucose lowering and weight reduction. One of the most promising classes in achieving these goals has been the glucagon-like peptide (GLP)-1 agonists. However, a difficult...
Na minha lista:
| Publicado no: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6897065/ https://ncbi.nlm.nih.gov/pubmed/31819577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S229802 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|